Vanguard National Trust
TWST icon

Vanguard National Trust’s Twist Bioscience TWST Stock Holding History

Vanguard National Trust’s Portfolio TWST Stock Details TWST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$19.8K Hold
192
– – ﹤0.01% 525
2026
Q1 		$9.12K Buy
+192
New +$8.61K ﹤0.01% 555

Other funds holding TWST

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $15.4B AUM 50.29% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
EIG
EdgePoint Investment Group Toronto, Ontario, Canada $13.2B AUM 32.43% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $33.3B AUM 44.76% 1-Year Est. Return

Vanguard National Trust's TWST Position: Q2 2026 in Review

Vanguard National Trust held its Twist Bioscience (TWST) position steady in Q2 2026 at 192 shares worth $19.8K. The position accounts for ﹤0.01% of the portfolio, ranked #525.

Vanguard National Trust first reported a position in TWST in Q1 2026 and has held it in 2 quarters since. 334 funds tracked by Wall St. Rank hold TWST as of Q2 2026.

  • Vanguard National Trust held 192 shares of Twist Bioscience worth $19.8K as of Q2 2026.
  • Vanguard National Trust left its Twist Bioscience share count unchanged in Q2 2026.
  • Twist Bioscience made up ﹤0.01% of Vanguard National Trust's portfolio in Q2 2026, its #525 holding.
  • Vanguard National Trust first reported a position in Twist Bioscience in Q1 2026 and has held it in 2 quarters since.
  • 334 funds tracked by Wall St. Rank held Twist Bioscience as of Q2 2026.

Based on Vanguard National Trust's 13F filing for Q2 2026, filed 13 Aug 2026.